£100K
The university spin-out has raised over £1m in total funding to develop targeted cancer therapeutics.
AO
Awen Oncology
Developing targeted anti-cancer drugs focusing on previously untargeted human developmental genes.
Gaerwen, UK—Founded 2021
£100KTotal raised
A Welsh university spin-out developing targeted anti-cancer therapeutics based on human developmental genes.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Awen Oncology's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Ramsay McFarlane
CEO
Ramsay is co-founder, director, and CEO of Awen Oncology. His background includes academic research leadership at Bangor University and North West Cancer Research.
LinkedInJW
Jane Wakeman
Andrea Brancale
Andrea brings academic and sector experience as chair of medicinal chemistry at UCT Prague and co-founder of Awen Oncology, following professorial and scientific leadership roles at Cardiff University and the Life Sciences Research Network Wales.
LinkedIn